FILANA THERAPEUTICS, INC. cotiza a 0.77 USD y tiene una capitalización bursátil de $37M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an ea…
| Periodo | 2026-10 | 2026-07 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.18 | $-0.21 | $-0.26 |
| Estimado | $-0.24 | $-0.22 | $-0.23 | $-0.30 |
| Sorpresa | — | +18.2% | +8.7% | +13.3% |
| Métrica | FLNA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -122.3% | -40.4% | -81.9% |
| ROA | -76.9% | -32.0% | -44.9% |
| Current Ratio | 2.23 | 2.84 | -0.61 |
| Debt / Equity | — | 0.28 | — |